Johannesburg Declaration, A civil society declaration to UN Secretary- General High Level Panel on Access to Medicines highlights the factors that interlink system of financing biodmedical research, innovation and access to health technologies. It denounces the research funding that relies upon the grant of monopolies which eventually ‘produces to innovation gaps, inefficiencies, and distortions in the development of new health technologies’. The declaration clearly recommends ‘the costs of medical research and development should be delinked from the price of health technologies.’
- IP Australia opens public consultation on proposed law changes
- Is India’s Expedited Examination Of Patents A Big Deal?
- Pharmaceutical Pricing Hostages
- DNDi welcomes Malaysia’s move to secure access to more affordable treatments for hepatitis C
- This Shield of Patents Protects the World’s Best-Selling Drug